Neuro and cardiac protection, Assists healing the gut (ibs and leaky gut), Improves immunity and sleep
EBioMedicine 74(103739):103739 Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, Saxena NK, Anania FA (2010) Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
Moxit Shah , a leading Endocrinologist in Ahmedabad , offers evidence-based medical weight loss programs using the latest GLP-1 medications, lifestyle modification, and long-term follow-up
Early findings highlight its potential ability to: Protect the mucosal lining Reduce inflammation markers Support vascular and tissue recovery But outcomes vary, and human studies are still ongoing
administration of the compound leads to a significant reduction in body weight without a drastic caloric deficit